These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8308885)

  • 1. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage.
    Capranico G; Palumbo M; Tinelli S; Mabilia M; Pozzan A; Zunino F
    J Mol Biol; 1994 Jan; 235(4):1218-30. PubMed ID: 8308885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational properties of topoisomerase II inhibitors and sequence specificity of DNA cleavage.
    Palumbo M; Mabilia M; Pozzan A; Capranico G; Tinelli S; Zunino F
    J Mol Recognit; 1994 Sep; 7(3):227-31. PubMed ID: 7880548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
    De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
    Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
    Capranico G; Butelli E; Zunino F
    Cancer Res; 1995 Jan; 55(2):312-7. PubMed ID: 7812964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
    Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
    Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
    Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180).
    Cornarotti M; Tinelli S; Willmore E; Zunino F; Fisher LM; Austin CA; Capranico G
    Mol Pharmacol; 1996 Dec; 50(6):1463-71. PubMed ID: 8967966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
    Fossé P; Charra M; Paoletti C; Saucier JM; René B
    Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
    Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
    J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structure-based 3D-QSAR study of anthrapyrazole analogues of the anticancer agents losoxantrone and piroxantrone.
    Liang H; Wu X; Guziec LJ; Guziec FS; Larson KK; Lang J; Yalowich JC; Hasinoff BB
    J Chem Inf Model; 2006; 46(4):1827-35. PubMed ID: 16859314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping drug interactions at the covalent topoisomerase II-DNA complex by bisantrene/amsacrine congeners.
    Capranico G; Guano F; Moro S; Zagotto G; Sissi C; Gatto B; Zunino F; Menta E; Palumbo M
    J Biol Chem; 1998 May; 273(21):12732-9. PubMed ID: 9582297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.
    Bigioni M; Zunino F; Tinelli S; Austin CA; Willmore E; Capranico G
    Biochemistry; 1996 Jan; 35(1):153-9. PubMed ID: 8555169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible and reversible topoisomerase II DNA cleavage stimulated by clerocidin: sequence specificity and structural drug determinants.
    Binaschi M; Zagotto G; Palumbo M; Zunino F; Farinosi R; Capranico G
    Cancer Res; 1997 May; 57(9):1710-6. PubMed ID: 9135013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD; Macdonald TL; Osheroff N
    Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
    Borgnetto ME; Tinelli S; Carminati L; Capranico G
    J Mol Biol; 1999 Jan; 285(2):545-54. PubMed ID: 9878428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin.
    Henichart JP; Waring MJ; Riou JF; Denny WA; Bailly C
    Mol Pharmacol; 1997 Mar; 51(3):448-61. PubMed ID: 9058600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
    Lown JW; Hanstock CC; Bradley RD; Scraba DG
    Mol Pharmacol; 1984 Jan; 25(1):178-84. PubMed ID: 6708933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of bis-substituted 2-aza-anthracenedione regioisomers to DNA: effects of the relative positioning of the side chains.
    Sissi C; Moro S; Zagotto G; Ellis M; Krapcho AP; Menta E; Palumbo M
    Anticancer Drug Des; 1999 Jun; 14(3):265-74. PubMed ID: 10500501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.